跳至主要内容
临床试验/ACTRN12615000377538
ACTRN12615000377538尚未招募3 期

Efficacy and safety of conservative versus liberal fluid therapy in critically ill patients with cirrhosis admitted to the intensive care unit

Professor Rinaldo Bellomo0 个研究点目标入组 40 人开始时间: 2015年4月23日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Adults (>18 years) admitted to ICU with decompensated cirrhosis
  • 2.Hypotension (Mean Arterial Pressure (MAP) <65mmHg)
  • 3.Clinical need for of a Central Venous Catheter (CVC) and arterial line (capable of cardiac output measurement (e.g. PiCCO or FloTrac)

排除标准

  • *Fulminant Hepatic Failure
  • *Oliguria requiring frusemide administration via a continuous infusion prior to or immediately on admission to ICU
  • *Renal failure requiring renal replacement therapy prior to or immediately on admission to ICU
  • *Diagnosis of Acute Respiratory Distress Syndrome (ARDS)
  • New, bilateral pulmonary infiltrates evident on chest X-Ray
  • Absence of clinical evidence for, or measured findings of left atrial hypertension
  • PaO2:FiO2 ratio of <200
  • *Severe pre-existing cardiopulmonary disease, e.g.;
  • NYHA class III or IV heart failure
  • Pulmonary hypertension
  • *Admission to ICU for severe bleeding (e.g. oesophageal varices complicated by haemorrhage)
  • *Requirement for total parenteral nutrition (TPN)

研究者

发起方
Professor Rinaldo Bellomo

相似试验